Current Report Filing (8-k)
15 November 2022 - 8:56AM
Edgar (US Regulatory)
0001443089
false
0001443089
2022-11-02
2022-11-02
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________
FORM 8-K
________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest event
Reported): November
2, 2022
Wearable
Health Solutions, Inc.
(Exact name of registrant as specified in its charter)
Nevada |
000-56368 |
26-3534190 |
(State of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
2901
W. Coast Highway, Suite 200,
Newport Beach, CA
92663
(Address of principal executive offices)
Phone: (949) 270 7460
(Registrant’s telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Not
applicable |
|
Not applicable |
|
Not applicable |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter):
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 7.01 – Regulation FD Disclosure
On November 2, 2022, the Company issued a press release titled “Wearable
Health Solutions, Inc. Signs First Enterprise Remote Patient Monitoring (“RPM”) Contract with Cleveland Based Physicians Group.”
The information contained in this Section 7.01 and in the exhibit attached
to this current report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act
of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act
of 1934, except as expressly set forth by specific reference in such filing.
Item
9.01 – Financial Statement and
Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange
Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Wearable Health Solutions, Inc. |
|
|
|
|
Date: November 14, 2022 |
By: /s/ Harrysen Mittler |
|
Harrysen Mittler |
|
Chief Executive Officer |
|
Principal Executive Officer |
Wearable Health Solutions (CE) (USOTC:WHSI)
Historical Stock Chart
From Dec 2024 to Jan 2025
Wearable Health Solutions (CE) (USOTC:WHSI)
Historical Stock Chart
From Jan 2024 to Jan 2025